INS and metabolic dysfunction-associated steatotic liver disease: Compared to controls, NAFLD patients had higher BMI, WC, SBP, DBP, ALT, AST, ALP, GGT, INS, GLU, HOMA-IR, TC, TG, and LDL but lower HDL-C.